STRATA Announces JCAD Publication: Photopneumatic Technology For The Treatment Of Mild-To-Moderate Acne Vulgaris
Portfolio Pulse from Happy Mohamed
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) announced that the Journal of Clinical and Aesthetic Dermatology published a review and an expert perspectives article on its TheraClearX system for the treatment of mild-to-moderate acne. The review highlighted the system's mechanism of action, key features, and clinical outcomes. The expert perspectives article emphasized the device's safety, efficacy, and visible improvement in patients after beginning treatment.
July 11, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
STRATA Skin Sciences' TheraClearX system received positive reviews in a medical journal, which could boost the company's reputation and potentially increase demand for the product.
The positive review and expert perspectives article published in a reputable medical journal could enhance STRATA Skin Sciences' reputation in the medical community. This could potentially lead to increased demand for the TheraClearX system, positively impacting the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100